← Eichor
Study identifier: NCT06902805 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.

Condition: Base-of-thumb Osteoarthritis · Osteoarthritis  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhasePhase 2/Phase 3
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main objective of this study will be to compare the effects of 2 intra-articular injections of onabotulinumtoxinA with those of 1 intra-articular injection of onabotulinumtoxinA and 1 of normal saline and those of 2 intra-articular injections of normal saline on base-of-thumb pain at 6 months after the first injection.

This description comes directly from the study's public registry record.

Talk to the study team

Christelle NGUYEN, MD, PhD  ·  01 58 41 29 45  ·  christelle.nguyen2@aphp.fr

Laetitia PEAUDECERF, PhD  ·  01 58 41 12 13  ·  laetitia.peaudecerf@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Assistance Publique - Hôpitaux de Paris, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis du Pr François Rannou, Hôpital CochinParis, Île-de-France Region, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06902805